APA (7th ed.) Citation

FJ, M., M, G., C, H., P, E., J, P., H, L., . . . CE, C. (2023). Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humans. Scientific reports, 13(1), 13904. https://doi.org/10.1038/s41598-023-40043-6

Chicago Style (17th ed.) Citation

FJ, Martinez, et al. "Immunogenicity of a Plasmodium Vivax Vaccine Based on the Duffy Binding Protein Formulated Using Adjuvants Compatible for Use in Humans." Scientific Reports 13, no. 1 (2023): 13904. https://doi.org/10.1038/s41598-023-40043-6.

MLA (9th ed.) Citation

FJ, Martinez, et al. "Immunogenicity of a Plasmodium Vivax Vaccine Based on the Duffy Binding Protein Formulated Using Adjuvants Compatible for Use in Humans." Scientific Reports, vol. 13, no. 1, 2023, p. 13904, https://doi.org/10.1038/s41598-023-40043-6.